Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1β, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

被引:0
|
作者
El-Shabrawi, Y [1 ]
Christen, WG [1 ]
Foster, CS [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Immunol & Uveitis Serv, Boston, MA 02114 USA
关键词
uveitis; matrix metalloproteinases; interleukin-1; beta; interleukin-1 receptor antagonists; interleukin-12; proinflammatory cytokines; human;
D O I
10.1076/0271-3683(200003)20:3;1-9;FT211
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Matrix metalloproteinases have been shown to play a role in active uveitis. Transcription of MMPs is induced by a number of growth factors and cytokines. This study investigates the role of MMPs in chronic uveitis and correlates the amounts of MMP-2 and -9 in intraocular samples to the intraocular levels of proinflammatory cytokines (Interleukin-1 [IL-1], Interleukin-12 [IL-12] and Interleukin-1 receptor antagonist [IL-1ra]). Methods. Aqueous humor of 16 patients was collected during surgical or diagnostic procedures (control group: cataract patients). MMP-2 and -9 were measured using zymography. IL-1, IL-12 and IL-1ra were evaluated by ELISA. Results. We found MMP-2 and -9 in all of our uveitis patients. In the control group only MMP-2 was seen. Higher levels of MMP-2 and -9 were found in patients with higher activity of uveitis (p < 0.014 for MMP-2, p < 0.0054 for MMP-9). The amounts of IL-1, IL-12 and IL-1ra detected in our uveitis patients correlated with levels of MMP-2 (p < 0.07, p < 0.0004, p < 0.03) and MMP-9 (p < 0.003, p < 0.0001, p < 0.002), and IL-12 (p < 0.004, p < 0.0001). Patients with moderately active uveitis presented with twice the level of MMP-2 as the control group; MMP-9 levels reached up to 92% of the amounts found in patients with active uveitis. Two patients in remission for almost one year still had detectable intraocular MMP-9 levels. Conclusion. Our data suggests that the high levels of MMPs found in patients with chronic uveitis might contribute to the damage often seen in these eyes. Since MMPs are capable of releasing proinflammatory cytokines bound to components of the extracellular matrix, and facilitate the secretion of active TNF-alpha by cleavage of the membrane bound form, it is conceivable that MMPs contribute to the chronicity of some uveitis cases.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 50 条
  • [41] Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites
    Ishihara, Y
    Nishihara, T
    Kuroyanagi, T
    Shirozu, N
    Yamagishi, E
    Ohguchi, M
    Koide, M
    Ueda, N
    Amano, K
    Noguchi, T
    JOURNAL OF PERIODONTAL RESEARCH, 1997, 32 (06) : 524 - 529
  • [42] GROWTH MODULATION OF HUMAN PROSTATIC-CANCER CELLS BY INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    HSIEH, TC
    CHIAO, JW
    CANCER LETTERS, 1995, 95 (1-2) : 119 - 123
  • [43] Over expression of interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist in testicular tissues from sexually immature mice as compared to adult mice
    Huleihel, M
    Lunenfeld, E
    Blindman, A
    Prinsloo, I
    Potashnik, G
    EUROPEAN CYTOKINE NETWORK, 2003, 14 (01) : 27 - 33
  • [44] Interleukin-1β and interleukin-1 receptor antagonist do not affect glutamate release or calcium entry in rat striatal synaptosomes
    Allan, SM
    Lawrence, CB
    Rothwell, NJ
    MOLECULAR PSYCHIATRY, 1998, 3 (02) : 178 - 182
  • [45] Immunohistochemical study of interleukin-1β and interleukin-1 receptor antagonist in an antigen-induced arthritis of the rabbit temporomandibular joint
    Habu, M
    Tominaga, K
    Sukedal, M
    Alstergren, P
    Ohkawara, S
    Kopp, S
    Fukuda, A
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (01) : 45 - 54
  • [46] Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells
    Higuchi, T
    Kuno, T
    Takahashi, S
    Kanmatsuse, K
    ARTIFICIAL ORGANS, 1997, 21 (04) : 265 - 271
  • [47] Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1β in gingival crevicular fluid and gingival tissues
    Yoshinari, N
    Kawase, H
    Mitani, A
    Ito, M
    Sugiishi, S
    Matsuoka, M
    Shirozu, N
    Ishihara, Y
    Bito, B
    Hiraga, M
    Arakawa, K
    Noguchi, T
    JOURNAL OF PERIODONTAL RESEARCH, 2004, 39 (03) : 158 - 167
  • [48] THE OVARIAN ACTION OF INTERLEUKIN-1 IS RECEPTOR-MEDIATED - REVERSAL BY A NATURALLY-OCCURRING INTERLEUKIN-1 RECEPTOR ANTAGONIST
    KOKIA, E
    BENSHLOMO, I
    ADASHI, EY
    FERTILITY AND STERILITY, 1995, 63 (01) : 176 - 181
  • [49] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 38 - 41
  • [50] Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring
    Tullus, K
    EscobarBilling, R
    Fituri, O
    Burman, LG
    Karlsson, A
    Wikstad, I
    Wretlind, B
    Brauner, A
    ACTA PAEDIATRICA, 1996, 85 (02) : 158 - 162